Table 1. IRF-1 AND IRF-2 IMMUNOHISTOCHEMICAL EXPRESSION IN DUCTAL CARCINOMA IN SITU

* Number of patients with positive staining/total number of patients.
Table 1. IRF-1 AND IRF-2 IMMUNOHISTOCHEMICAL EXPRESSION IN DUCTAL CARCINOMA IN SITU

* Number of patients with positive staining/total number of patients.